Your browser doesn't support javascript.
loading
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi'an, China.
Lu, Yongkai; Chen, Ruijuan; Li, Yi.
Afiliación
  • Lu Y; Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277, Yanta West Road, Xi'an, 710061, Shaanxi, China. luyongkai@xjtufh.edu.cn.
  • Chen R; Xi'an Central Hospital, The Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710003, Shaanxi, China.
  • Li Y; Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, No. 277, Yanta West Road, Xi'an, 710061, Shaanxi, China.
Med Oncol ; 39(5): 79, 2022 Feb 23.
Article en En | MEDLINE | ID: mdl-35195791
This letter is some reflections on the articles by Lee et al. that have been published in MEDICAL ONCOLOGY. In this article, the experience of transferring, screening, and uninterrupted treatment of cancer patients in our radiotherapy center during Delta Variants of SARS-CoV-2 virus epidemic in Xi'an, China is presented in the form of a flowchart. By taking effective control measures, the radiotherapy center has not only effectively prevented the spread of the virus, but also ensured uninterrupted treatment for all patients. Therefore, we quickly share our center's experience so that more radiotherapy patients can benefit.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Med Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos